ResultsIQ

ResultsIQ › Latest results › Novartis India Limited

Novartis India Limited strategy deck summary

NSE: NOVARTIND · BSE: 500672

Strategy deck of 11 Sep 2026, summarised by AI from the filing.

NIL acquired Minipress trademark rights from Pfizer Inc. for ₹1,250 cr; brand revenue was ₹228 cr (MAT Jul'26).

Key takeaways

  1. Minipress XL NIL acquired Minipress trademark rights from Pfizer Inc. for ₹1,250 cr; brand revenue was ₹228 cr (MAT Jul'26).
  2. Field force A 900+ member field force is planned to cover ~150,000 HCPs pan-India, replacing partner-led distribution.
  3. Revenue trend Revenue declined from ₹379 cr in FY23 to ₹335 cr in FY26, a -2% CAGR.

Original filing on BSE

Novartis India Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.